Effects of the levonorgestrel-releasing intrauterine system on cervical mucus quality and sperm penetrability

Contraception
Radha A LewisD R Mishell

Abstract

In levonorgestrel intrauterine system (LNG-IUS) users, the prevention of sperm penetration through cervical mucus has not been demonstrated. Subjects were enrolled in an investigator-blinded study to compare quality and sperm penetrability of mid-cycle cervical mucus between LNG-IUS users and hormone-free controls. Cervical mucus was microscopically examined using World Health Organization (WHO) cervical mucus analysis (CMA). CMA score ≥10 of 15 points indicated cervical mucus favoring sperm penetration. Mucus was incubated with sperm using the WHO simplified slide test (SST) and Kremer sperm cervical mucus penetration test (SCMPT). Data from 14 LNG-IUS users and 16 controls showed 14% of LNG-IUS users had CMA score ≥10% vs. 69% of controls (p=.004). SST showed no sperm penetration for LNG-IUS users, significantly less than controls (0% vs. 64.3%, p<.001). SCMPT demonstrated no sperm mucus penetration for LNG-IUS users at 2 and 6 h (0% vs. 85% in controls with 2-h score ≥6, p<.001; 6 h 0% vs. 79% in controls, p<.001). Mid-cycle cervical mucus of LNG-IUS users is poor quality and prevents endocervical sperm transport in vitro.

References

Jun 1, 1995·Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception·I BarbosaE Coutinho
Jan 17, 2002·The New England Journal of Medicine·D S GuzickUNKNOWN National Cooperative Reproductive Medicine Network

❮ Previous
Next ❯

Citations

Nov 6, 2013·Antiviral Research·David R FriendMeredith R Clark
Oct 15, 2014·Clinical Obstetrics and Gynecology·Pamela A Royer, Kirtly P Jones
May 3, 2013·Obstetrics and Gynecology·David HubacherKristina Gemzell-Danielsson
Jul 28, 2012·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Kirsten BlackNikki B Zite
Sep 11, 2012·Current Problems in Pediatric and Adolescent Health Care·Lauren B HartmanLoris Y Hwang
Aug 23, 2011·Acta Obstetricia Et Gynecologica Scandinavica·Kristina Gemzell-DanielssonOskari Heikinheimo
Mar 26, 2014·American Journal of Obstetrics and Gynecology·Catherine A ChappellSharon L Hillier
Oct 14, 2011·American Journal of Obstetrics and Gynecology·Uta Landy, Philip D Darney
Jun 12, 2012·Contraception·Rachel StewardDaniel R Mishell
Apr 30, 2016·Contraception·Mitchell D CreininAndrea Olariu
Jun 9, 2016·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Leticia G MoraesLuis Bahamondes
Mar 26, 2013·Human Reproduction·Janina KaislasuoOskari Heikinheimo
Dec 19, 2016·American Journal of Obstetrics and Gynecology·Rachel E Zigler, Colleen McNicholas
Jun 19, 2017·Contraception·Christine M BassisJason D Bell
May 21, 2016·Substance Abuse : Research and Treatment·Kirsten I Black, Carolyn A Day
Oct 25, 2017·Obstetrics and Gynecology·UNKNOWN Committee on Practice Bulletins-Gynecology, Long-Acting Reversible Contraception Work Group
Feb 2, 2019·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Hannat Akintomide
Mar 29, 2019·Reproduction : the Official Journal of the Society for the Study of Fertility·S FairS P de Graaf
Jul 5, 2018·Journal of Medical Primatology·Ov Daniel SlaydenEmily Cathleen Mishler
May 1, 2011·The Linacre Quarterly·Richard J Fehring
Nov 13, 2020·BMJ : British Medical Journal·Jennifer J YlandLauren A Wise

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.